0.6499
Schlusskurs vom Vortag:
$0.6684
Offen:
$0.66
24-Stunden-Volumen:
802.65K
Relative Volume:
0.06
Marktkapitalisierung:
$67.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-225.14M
KGV:
-0.3316
EPS:
-1.96
Netto-Cashflow:
$-192.27M
1W Leistung:
+27.43%
1M Leistung:
-1.49%
6M Leistung:
-33.28%
1J Leistung:
-68.60%
Invivyd Inc Stock (IVVD) Company Profile
Firmenname
Invivyd Inc
Sektor
Branche
Telefon
(781) 819-0080
Adresse
1601 TRAPELO ROAD, WALTHAM
Vergleichen Sie IVVD mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
IVVD
Invivyd Inc
|
0.6499 | 67.30M | 0 | -225.14M | -192.27M | -1.96 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
493.84 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
602.64 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
614.76 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
251.56 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
244.90 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-04-05 | Hochstufung | Guggenheim | Neutral → Buy |
2024-03-26 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2023-12-19 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
2023-05-01 | Eingeleitet | H.C. Wainwright | Buy |
Invivyd Inc Aktie (IVVD) Neueste Nachrichten
What is Invivyd Inc (IVVD) Stock Return on Shareholders’ Capital? - Sete News
Guggenheim upgrades Invivyd Inc (IVVD) rating to a Buy - knoxdaily.com
Danaher expects about $350M in tariff costs; Alumis, Acelyrin adjust deal terms - Endpoints News
IVVD Stock Price and Chart — NASDAQ:IVVD - TradingView
Invivyd (IVVD) Secures $30M Loan Facility from Silicon Valley Ba - GuruFocus
Invivyd Inc (IVVD) Stock: A Comprehensive 52-Week Review - investchronicle.com
Invivyd secures $30 million loan for COVID-19 antibody development By Investing.com - Investing.com South Africa
What's Going On With Invivyd Stock On Monday? - AOL.com
Invivyd Announces $30 Million Loan Facility With Silicon Valley Bank - citybiz
Invivyd (IVVD) Secures $30 Million Loan Facility from Silicon Valley Bank - GuruFocus
Invivyd gets $30M term loan facility from Silicon Valley Bank - MSN
Invivyd Secures $30 Million Loan from SVB - TipRanks
Invivyd (IVVD) Secures $30M Loan Facility from Silicon Valley Bank | FCNCA Stock News - GuruFocus
Invivyd Enters $30 Mln Term Loan Facility With Silicon Valley Bank - Nasdaq
Invivyd secures $30 million loan for COVID-19 antibody development - Investing.com
Invivyd, Inc. Secures $30 Million Term Loan Facility from Silicon Valley Bank to Advance Viral Infectious Disease Pipeline - Nasdaq
Invivyd Lands Strategic $30M Financing Deal: What This Means for VYD2311's FDA Journey - Stock Titan
Invivyd - WACH
Invivyd Inc (NASDAQ: IVVD) – Analysts’ Views Revised To A Positive - stocksregister.com
Invivyd, Inc. (NASDAQ:IVVD) Sees Large Drop in Short Interest - MarketBeat
Invivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of Directors - The Manila Times
Invivyd Appoints Ajay Royan to its Board of Directors - citybiz
Invivyd adds venture capitalist Ajay Royan to board By Investing.com - Investing.com South Africa
Invivyd Appoints Ajay Royan to Board of Directors - TipRanks
Invivyd adds venture capitalist Ajay Royan to board - Investing.com India
Invivyd’s (IVVD) Buy Rating Reiterated at D. Boral Capital - Defense World
Invivyd, Inc. (IVVD) Reports Q4 Loss, Tops Revenue Estimates - MSN
INVIVYD SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. – IVVD, ADGI - Business Wire
Invivyd Reports Strong Revenue Growth and Promising Developments - TipRanks
Invivyd earnings beat by $0.08, revenue fell short of estimates - Investing.com Canada
Invivyd, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 -March 20, 2025 at 08:12 am EDT - MarketScreener
Invivyd, Inc. SEC 10-K Report - TradingView
Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights - The Manila Times
Invivyd, Inc. Reports 48% Q4 Revenue Growth for PEMGARDA™ and Advances Next-Generation Antibody VYD2311 - Nasdaq
Invivyd, Inc. Full Year Loss Decreases, But Misses Estimates - Nasdaq
Invivyd (IVVD) Projected to Post Earnings on Thursday - Defense World
Are Investors Undervaluing Invivyd, Inc. (IVVD) Right Now? - Yahoo Finance
D. Boral Capital Reiterates Buy Rating for Invivyd (NASDAQ:IVVD) - MarketBeat
Invivyd reports pemivibart maintains efficacy against SARS-CoV-2 By Investing.com - Investing.com Canada
Invivyd reports pemivibart maintains efficacy against SARS-CoV-2 - Investing.com India
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1 - The Manila Times
Invivyd's COVID Treatment Still Works Against Elusive LP.8.1 VariantCritical News for Immunocompromised Patients - StockTitan
Invivyd (NasdaqGM:IVVD) Jumps 163% After Promising Phase 1/2 Trial Results For COVID-19 Antibody - Simply Wall St
Invivyd Inc [IVVD] Insider Activity: An Update for Investors - Knox Daily
Invivyd Inc’s Banking’s 100-Day Moving Average at 0.8392: Will the Stock Break Through? - investchronicle.com
Why Invivyd, Inc. (IVVD) is Skyrocketing So Far in 2025 - Insider Monkey
Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey
D. Boral Capital Reiterates “Buy” Rating for Invivyd (NASDAQ:IVVD) - Armenian Reporter
The Zacks Analyst Blog Highlights INVIVYD, 21Vianet, FuboTV, Noodles and Digital Turbine - Yahoo Finance
Invivyd (NASDAQ:IVVD) Receives “Buy” Rating from D. Boral Capital - Defense World
Invivyd (NASDAQ:IVVD) Given “Buy” Rating at HC Wainwright - Defense World
Finanzdaten der Invivyd Inc-Aktie (IVVD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Invivyd Inc-Aktie (IVVD) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
MCGUIRE TERRANCE | Director |
Dec 27 '24 |
Sale |
0.52 |
83,744 |
43,647 |
3,256,776 |
MCGUIRE TERRANCE | Director |
Dec 30 '24 |
Sale |
0.48 |
86,545 |
41,784 |
3,170,231 |
MCGUIRE TERRANCE | Director |
Dec 20 '24 |
Sale |
0.42 |
119,805 |
50,725 |
3,568,274 |
MCGUIRE TERRANCE | Director |
Dec 26 '24 |
Sale |
0.54 |
83,817 |
45,563 |
3,340,520 |
MCGUIRE TERRANCE | Director |
Dec 24 '24 |
Sale |
0.51 |
68,161 |
34,503 |
3,424,337 |
MCGUIRE TERRANCE | Director |
Dec 23 '24 |
Sale |
0.45 |
75,776 |
34,076 |
3,492,498 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):